Search Results - "Talbot, Susan M."

Combined heart and lung transplantation for unresectable primary cardiac sarcoma by Talbot, Susan M., Taub, Robert N., Keohan, Mary Lou, Edwards, Niloo, Galantowicz, Mark E., Schulman, Larry L.

“…Objective: The prognosis for patients with primary cardiac sarcoma is poor. Median survival is less than 10 months, especially when complete surgical excision…”
Get full text

A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma by Talbot, Susan M., Keohan, Mary Louise, Hesdorffer, Mary, Orrico, Russell, Bagiella, Emilia, Troxel, Andrea B., Taub, Robert N.

“…BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable…”
Get full text

High-dose ifosfamide with mesna and granuloctye-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma: A Southwest Oncology Group Study by TALBOT, Susan M, RANKIN, Cathryn, TAUB, Robert N, BALCERZAK, Stanley P, BHOOPALAM, Nirmala, CHAPMAN, Robert A, BAKER, Laurence H, MIDDLEMAN, Edward L, ANTMAN, Karen H

Get full text

Integration of palliative care services into standard oncology practice at diagnosis of metastatic lung cancer at VA New York Harbor Healthcare System by Rivera Mercado, Felix Manuel, Luhrs, Carol, Beal, Alice, Langdon, Maura, Secrest, Joan, Talbot, Susan M.

“…Abstract only 165 Background: The 2012 ASCO provisional clinical opinion addressed the integration of palliative care into standard oncology practice at the…”
Get full text

High‐dose ifosfamide with mesna and granuloctye–colony‐stimulating factor (recombinant human G‐CSF) in patients with unresectable malignant mesothelioma by Talbot, Susan M., Rankin, Cathryn, Taub, Robert N., Balcerzak, Stanley P., Bhoopalam, Nirmala, Chapman, Robert A., Baker, Laurence H., Middleman, Edward L., Antman, Karen H.

“…BACKGROUND The current study was conducted to assess the activity and toxicity of high‐dose ifosfamide and mesna with recombinant human…”
Get full text

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma by Talbot, Susan M, Rankin, Cathryn, Taub, Robert N, Balcerzak, Jr, Stanley P, Bhoopalam, Nirmala, Chapman, Robert A, Baker, Laurence H, Middleman, Edward L, Antman, Karen H

“…The current study was conducted to assess the activity and toxicity of high-dose ifosfamide and mesna with recombinant human granulocyte-colony-stimulating…”
Get full text